{
  "id": 14942413,
  "title": "New treatment for inflammatory bowel disease lands Microbiotica €42 million",
  "url": "https://urgent.news/2026/10/16/new-treatment-for-inflammatory-bowel-disease-lands-microbiotica-42",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-16T11:12:28.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/10/new-treatment-for-inflammatory-bowel-disease-lands-microbiotica-e42-million/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Microbiotica, a British clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines, today announces the first close of a €42 million (£36 million) Series C financing. The financing was led by British Business Bank, with participation from Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, and Seventure Partners. All existing Series B…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}